These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
443 related articles for article (PubMed ID: 25193380)
1. Epigenetic enzymes are the therapeutic targets for CD4(+)CD25(+/high)Foxp3(+) regulatory T cells. Lopez-Pastrana J; Shao Y; Chernaya V; Wang H; Yang XF Transl Res; 2015 Jan; 165(1):221-40. PubMed ID: 25193380 [TBL] [Abstract][Full Text] [Related]
2. Histone methylation mediates plasticity of human FOXP3(+) regulatory T cells by modulating signature gene expressions. He H; Ni B; Tian Y; Tian Z; Chen Y; Liu Z; Yang X; Lv Y; Zhang Y Immunology; 2014 Mar; 141(3):362-76. PubMed ID: 24152290 [TBL] [Abstract][Full Text] [Related]
3. Methylation of FOXP3 in regulatory T cells is related to the severity of coronary artery disease. Jia L; Zhu L; Wang JZ; Wang XJ; Chen JZ; Song L; Wu YJ; Sun K; Yuan ZY; Hui R Atherosclerosis; 2013 Jun; 228(2):346-52. PubMed ID: 23566804 [TBL] [Abstract][Full Text] [Related]
4. Induction of Foxp3 demethylation increases regulatory CD4+CD25+ T cells and prevents the occurrence of diabetes in mice. Zheng Q; Xu Y; Liu Y; Zhang B; Li X; Guo F; Zhao Y J Mol Med (Berl); 2009 Dec; 87(12):1191-205. PubMed ID: 19841877 [TBL] [Abstract][Full Text] [Related]
5. Epigenetical Targeting of the FOXP3 Gene by S-Adenosylmethionine Diminishes the Suppressive Capacity of Regulatory T Cells Ex Vivo and Alters the Expression Profiles. Sahin E; Sahin M J Immunother; 2019 Jan; 42(1):11-22. PubMed ID: 30407230 [TBL] [Abstract][Full Text] [Related]
6. Histone deacetylase inhibitors and transplantation. Tao R; de Zoeten EF; Ozkaynak E; Wang L; Li B; Greene MI; Wells AD; Hancock WW Curr Opin Immunol; 2007 Oct; 19(5):589-95. PubMed ID: 17719760 [TBL] [Abstract][Full Text] [Related]
7. Transcriptional and epigenetic basis of Treg cell development and function: its genetic anomalies or variations in autoimmune diseases. Ohkura N; Sakaguchi S Cell Res; 2020 Jun; 30(6):465-474. PubMed ID: 32367041 [TBL] [Abstract][Full Text] [Related]
9. Critical stoichiometric ratio of CD4(+) CD25(+) FoxP3(+) regulatory T cells and CD4(+) CD25(-) responder T cells influence immunosuppression in patients with B-cell acute lymphoblastic leukaemia. Bhattacharya K; Chandra S; Mandal C Immunology; 2014 May; 142(1):124-39. PubMed ID: 24354800 [TBL] [Abstract][Full Text] [Related]
10. Deacetylase inhibitor trichostatin A down-regulates Foxp3 expression and reduces CD4+CD25+ regulatory T cells. Liu Z; Zhang C; Sun J Biochem Biophys Res Commun; 2010 Sep; 400(3):409-12. PubMed ID: 20801101 [TBL] [Abstract][Full Text] [Related]
11. Forkhead box P3: the peacekeeper of the immune system. Passerini L; Santoni de Sio FR; Roncarolo MG; Bacchetta R Int Rev Immunol; 2014 Mar; 33(2):129-45. PubMed ID: 24354325 [TBL] [Abstract][Full Text] [Related]
12. Epigenetic regulation of Foxp3 expression in regulatory T cells by DNA methylation. Lal G; Zhang N; van der Touw W; Ding Y; Ju W; Bottinger EP; Reid SP; Levy DE; Bromberg JS J Immunol; 2009 Jan; 182(1):259-73. PubMed ID: 19109157 [TBL] [Abstract][Full Text] [Related]
13. Abnormal acetylation of FOXP3 regulated by SIRT-1 induces Treg functional deficiency in patients with abdominal aortic aneurysms. Jiang H; Xin S; Yan Y; Lun Y; Yang X; Zhang J Atherosclerosis; 2018 Apr; 271():182-192. PubMed ID: 29524861 [TBL] [Abstract][Full Text] [Related]
14. Loss of FOXP3 expression in natural human CD4+CD25+ regulatory T cells upon repetitive in vitro stimulation. Hoffmann P; Boeld TJ; Eder R; Huehn J; Floess S; Wieczorek G; Olek S; Dietmaier W; Andreesen R; Edinger M Eur J Immunol; 2009 Apr; 39(4):1088-97. PubMed ID: 19283780 [TBL] [Abstract][Full Text] [Related]
15. Blockade of TGF-β signaling to enhance the antitumor response is accompanied by dysregulation of the functional activity of CD4 Polanczyk MJ; Walker E; Haley D; Guerrouahen BS; Akporiaye ET J Transl Med; 2019 Jul; 17(1):219. PubMed ID: 31288845 [TBL] [Abstract][Full Text] [Related]
16. Epigenetic and transcriptional control of Foxp3+ regulatory T cells. Huehn J; Beyer M Semin Immunol; 2015 Feb; 27(1):10-8. PubMed ID: 25801206 [TBL] [Abstract][Full Text] [Related]
17. The significantly enhanced frequency of functional CD4+CD25+Foxp3+ T regulatory cells in therapeutic dose aspirin-treated mice. Javeed A; Zhang B; Qu Y; Zhang A; Sun C; Zhang L; Liu J; Zeng C; Zhao Y Transpl Immunol; 2009 Mar; 20(4):253-60. PubMed ID: 19146957 [TBL] [Abstract][Full Text] [Related]
18. Mechanisms of human FoxP3 Attias M; Al-Aubodah T; Piccirillo CA Clin Exp Immunol; 2019 Jul; 197(1):36-51. PubMed ID: 30864147 [TBL] [Abstract][Full Text] [Related]
19. CD4+Foxp3+ regulatory T cells converted by rapamycin from peripheral CD4+CD25(-) naive T cells display more potent regulatory ability in vitro. Chen JF; Gao J; Zhang D; Wang ZH; Zhu JY Chin Med J (Engl); 2010 Apr; 123(7):942-8. PubMed ID: 20497692 [TBL] [Abstract][Full Text] [Related]
20. Tumor Necrosis Factor-producing T-regulatory Cells Are Associated With Severe Liver Injury in Patients With Acute Hepatitis A. Choi YS; Jung MK; Lee J; Choi SJ; Choi SH; Lee HW; Lee JJ; Kim HJ; Ahn SH; Lee DH; Kim W; Park SH; Huh JR; Kim HP; Park JY; Shin EC Gastroenterology; 2018 Mar; 154(4):1047-1060. PubMed ID: 29229400 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]